[Reoperation for thyroid cancer].
Reoperation for thyroid cancer needs to consider patient-, tumor- and therapy-related aspects as well as present diagnostic results. Reoperation because of thyroid remnants, persistence of the primary tumor and lymph node metastasis (completion surgery) has to be distinguished from reoperation due to locoregional recurrence (primary tumor, lymph nodes). The primary surgical strategy should avoid the need for reoperation. The extent of reoperation is related to the extent of primary surgery, stage, and distant metastasis. The timing and indication of reoperation for differentiated thyroid carcinoma in an interdisciplinary multimodal treatment setting depends on diagnostic radioiodine scans and radioiodine therapy. Long-term, recurrence-free survival is achieved by sufficiently radical surgery with acceptable morbidity, including all additive or adjuvant treatment options.
Vogelsang
H
H
Chirurgische Klinik und Poliklinik, Technische Universität München. vogelsang@nt1.chir.med.tu-muenchen.de
Brückner
T
T
Scheidhauer
K
K
Schwaiger
M
M
Siewert
J R
JR
D018450:Disease Progression; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D011379:Prognosis; D012009:Recurrent Laryngeal Nerve / Q000473:pathology; D061226:Recurrent Laryngeal Nerve Injuries; D012086:Reoperation; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D013965:Thyroidectomy / Q000379:methods*
Lancet Oncol. 2002 Jul;3(7):407-14
12142170
J Surg Res. 2001 May 1;97(1):9-13
11319873
J Clin Endocrinol Metab. 1992 Sep;75(3):714-20
1517360
Surg Oncol Clin N Am. 1996 Jan;5(1):43-63
8789493
J Clin Endocrinol Metab. 1986 Oct;63(4):960-7
3745409
Cancer. 1987 Nov 15;60(10):2372-5
3664425
Endocr Pract. 2001 May-Jun;7(3):202-20
11430305
Thyroidology. 1993 Dec;5(3):93-6
7524636
Am J Med. 1994 Nov;97(5):418-28
7977430
Br J Surg. 1993 Aug;80(8):1009-12
8402050
Tumori. 2000 Jul-Aug;86(4):367-9
11016732
Lancet. 2003 Feb 8;361(9356):501-11
12583960
World J Surg. 1998 Jun;22(6):562-7; discussion 567-8
9597929
World J Surg. 1992 Jul-Aug;16(4):711-6; discussion 716-7
1413840
Surgery. 1997 Dec;122(6):1124-30; discussion 1130-1
9426428
Thyroid. 2004 Aug;14(8):600-4
15320972
Chirurg. 2004 Sep;75(9):916-22
15168032
Surgery. 1992 Dec;112(6):1139-46; discussion 1146-7
1455316
Cancer. 1994 Aug 15;74(4):1348-54
8055459
Cancer. 2003 Mar 1;97(5):1186-94
12599224
World J Surg. 1994 Jul-Aug;18(4):559-67; discussion 567-8
7725745
World J Surg. 1996 Sep;20(7):860-6; discussion 866
8678963
Chirurg. 1996 Aug;67(8):788-806
8964151
J Clin Oncol. 2001 May 15;19(10):2616-25
11352953
Nucl Med Commun. 2004 Sep;25(9):897-900
15319594
Ann Chir. 2003 Jun;128(5):289-92
12878063
J Clin Endocrinol Metab. 1998 Aug;83(8):2675-80
9709930
Eur J Nucl Med. 1999 Aug;26(8):913-35
10436207
World J Surg. 2002 Jan;26(1):22-8
11898029
Curr Treat Options Oncol. 2004 Aug;5(4):307-13
15233907
Zentralbl Chir. 2002 May;127(5):435-8
12058304
Arch Surg. 2000 Aug;135(8):895-901
10922248
Endocrinol Metab Clin North Am. 1990 Sep;19(3):545-76
2261906
Eur J Surg. 1996 Sep;162(9):677-84
8908447